In the current study, our results could not reveal if increased liver inflammation in the Osr1+/- mice is a cause or a consequence of the steatosis, thus it is unclear if the worsened steatosis or the enhanced hepatic inflammation is the driving force for NAFLD progression. Here, OSR1 is linked to metabolic dysfunction-associated steatotic liver disease.